(Q39882778)

15 September 2017

Progressive liver failure induced by everolimus for renal cell carcinoma in a 58-year-old male hepatitis B virus carrier (English)

1 reference

15 September 2017

1 reference

1 reference

1 reference

10

Toshifumi Hibi

1 reference

15 September 2017

7

Michiie Sakamoto

1 reference

15 September 2017

Shinta Mizuno

1

1 reference

15 September 2017

Yoshiyuki Yamagishi

2

1 reference

15 September 2017

Hirotoshi Ebinuma

3

1 reference

15 September 2017

Nobuhiro Nakamoto

4

1 reference

15 September 2017

Mai Katahira

5

1 reference

15 September 2017

Aya Sasaki

6

1 reference

15 September 2017

Hidekazu Suzuki

8

1 reference

15 September 2017

Takanori Kanai

9

1 reference

15 September 2017

14 March 2013

1 reference

Clinical journal of gastroenterology

15 September 2017

1 reference

15 September 2017

6

1 reference

15 September 2017

2

1 reference

15 September 2017

188-192

1 reference

Creative Commons Attribution 2.0 Generic

15 September 2017

start time

14 March 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1007/s12328-013-0371-4

0 references

cites work

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3627850

Novel feedback inhibition of surface antigen synthesis by mammalian target of rapamycin (mTOR) signal and its implication for hepatitis B virus tumorigenesis and therapy.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3627850

Reactivation of hepatitis B virus infection after cytotoxic chemotherapy or immunosuppressive therapy

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3627850

Everolimus in the treatment of renal cell carcinoma and neuroendocrine tumors

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3627850

Reactivation of hepatitis B.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3627850

Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3627850

Hepatitis B virus reactivation following immunosuppressive therapy: guidelines for prevention and management.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3627850

Prevention of hepatitis B virus reactivation in patients receiving immunosuppressive therapy or chemotherapy

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3627850

Comparison of entecavir and lamivudine in preventing hepatitis B reactivation in lymphoma patients during chemotherapy.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3627850

Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3627850

Mortality secondary to fulminant hepatic failure in patients with prior resolution of hepatitis B virus infection in Japan

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3627850

Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy

20 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23606919

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Therapeutic effect of a new immunosuppressive agent, everolimus, on interleukin-10 gene-deficient mice with colitis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23606919

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S12328-013-0371-4

1 reference

15 September 2017

1 reference

15 September 2017

PubMed publication ID

23606919

1 reference